Marksans Pharma Limited has informed the Exchange regarding a press release dated August 26, 2021, titled "Marksans Pharma Limited announces USFDA approval for Acetaminophen Extended-Release Tablets USP, 650 mg (OTC)".
Press Release Aug 26 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Marksans Pharma Limited on 6ix
Earlier from Marksans Pharma
- Press Release Aug 11 2021
- Press Release Jul 10 2021
- Press Release May 31 2021
- Press Release Nov 06 2020
- Press Release Oct 03 2020
Later from Marksans Pharma
- Press Release Nov 10 2021
- Press Release Dec 09 2021
- Press Release Jan 11 2022
- Press Release Feb 22 2022
- Press Release Apr 25 2022
Follow Marksans Pharma into a list and get an email when it puts out news.
Follow Marksans Pharma